{"pageContent": "Prostate cancer is the most common cancer among men in the UK. It is a disease with no specific preventable risk factors, no specific signs and symptoms, and a significant health burden. This article explains the various treatment options available for patients with prostate cancer, with the aim of assisting nurses in supporting person-centred decision-making. It also discusses the risk factors, signs and symptoms, diagnosis, staging, grading and risk stratification of prostate cancer.", "metaData": {"source": "Genetic variants in CASP3, BMP5, and IRS2 genes may influence survival in prostate cancer patients receiving androgen-deprivation therapy\nhttps://pubmed.ncbi.nlm.nih.gov/22844442/"}}